<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Ganglionated plexi (GP) ablation has been shown to play an important role in <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) initiation and maintenance </plain></SENT>
<SENT sid="1" pm="."><plain>Also, GP ablation increases chances for prevention of AF recurrence </plain></SENT>
<SENT sid="2" pm="."><plain>This study investigated the effects of GP ablation on ventricular electrophysiological properties in <z:mpath ids='MPATH_458'>normal</z:mpath> dog hearts and after <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Fifty anesthetized dogs were assigned into <z:mpath ids='MPATH_458'>normal</z:mpath> heart group (n=16) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> heart group (n=34) </plain></SENT>
<SENT sid="4" pm="."><plain>Ventricular dynamic restitution, effective refractory period (ERP), electrical alternans and <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> threshold (VFT) were measured before and after GP ablation in the <z:mpath ids='MPATH_458'>normal</z:mpath> heart group </plain></SENT>
<SENT sid="5" pm="."><plain>In the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> heart group, the incidence of <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> and VFT were determined </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In the <z:mpath ids='MPATH_458'>normal</z:mpath> heart group, GP ablation significantly prolonged ERP, facilitated electrical alternans but did not increase ERP dispersion, the slope of restitution curves and its spatial dispersion </plain></SENT>
<SENT sid="7" pm="."><plain>Also, GP ablation did not cause significant change of VFT </plain></SENT>
<SENT sid="8" pm="."><plain>In the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> heart group, the incidence of <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> after GP ablation was significantly higher than that in the control group or the GP plus stellate ganglion (SG) ablation group (P&lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>Spontaneous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> occurred in 8/12, 1/10 and 2/12 dogs in the GP ablation group, the GP plus SG ablation group and the control group, respectively (P&lt;0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>VFT in the GP ablation group showed a decreased trend though a significant difference was not achieved compared with the control or the GP plus SG ablation group </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: GP ablation increases the risk of <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> heart compared to the <z:mpath ids='MPATH_458'>normal</z:mpath> heart </plain></SENT>
</text></document>